Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Neck Dissection × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Tongue Neoplasms 1 Thyroid Neoplasms 1 Pain, Postoperative 1 Mouth Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Cisplatin 43 Carboplatin 38 pembrolizumab 36 Paclitaxel 32 Gemcitabine 27 Pemetrexed 18 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Radiotherapy, Intensity-Modulated 16 Docetaxel 16 Cetuximab 15 Nivolumab 14 Specimen Handling 13 Cyclophosphamide 13 durvalumab 12 Fluorouracil 12 130-nm albumin-bound paclitaxel 10 Platinum 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Bevacizumab 8 1,2-diaminocyclohexaneplatinum II citrate 8 Oxaliplatin 7 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡